Arkolith/Insider Trading/NYMX/Form 4/A

Robinson James George

Director, 10% OwnerNYMOX PHARMACEUTICAL CORP (NYMX) · full profile →Form 4/A · filed May 18, 2023
Net Buying
Open-Market Buys
$18K
Open-Market Sells
$0
Net Open-Market Flow
$18K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 25, 2023Buy(P)40K$0.45$18K4.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001729637-23-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML